Becton, Dickinson and Company logo

Becton, Dickinson and Company (BDX)

Market Closed
13 Jun, 20:00
NYSE NYSE
$
172. 21
-2.25
-1.29%
$
49.5B Market Cap
- P/E Ratio
3.8% Div Yield
2,276,400 Volume
- Eps
$ 174.46
Previous Close
Day Range
171.87 176.33
Year Range
163.33 251.99
Earnings results expected in 46 days
Want to track BDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BD Reaches Agreement to Resolve Vast Majority of Hernia Litigation

BD Reaches Agreement to Resolve Vast Majority of Hernia Litigation

No admission of liability or wrongdoing; settlement structured to eliminate uncertainty for all stakeholders related to settled cases. Settlement amount within current product litigation reserve and will be paid out over a multi-year period.

Prnewswire | 8 months ago
New Data Reveals BD's Artificial Intelligence Software Highly Effective in Detecting Indicators of Controlled Substance Diversion

New Data Reveals BD's Artificial Intelligence Software Highly Effective in Detecting Indicators of Controlled Substance Diversion

FRANKLIN LAKES, N.J. , Sept. 26, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new data that highlights how its advanced artificial intelligence technology can help health systems better identify incidents of controlled substance diversion in the operating room.

Prnewswire | 8 months ago
4 Stocks to Buy Amid Dental Supplies Industry Challenges

4 Stocks to Buy Amid Dental Supplies Industry Challenges

Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include BDX, MCK, COO and STAA.

Zacks | 8 months ago
BD Stock Rises as Neopak XtraFlow Syringe Expands in Biologics

BD Stock Rises as Neopak XtraFlow Syringe Expands in Biologics

BDX launches the Neopak XtraFlow Glass Prefillable Syringe, enhancing drug delivery for biologics and expanding capacity with new high-volume production lines.

Zacks | 8 months ago
BD Expands Capacity for Advanced Prefillable Syringes and Enhances Injection Experience for the Next Generation of Biologics

BD Expands Capacity for Advanced Prefillable Syringes and Enhances Injection Experience for the Next Generation of Biologics

LE PONT-DE-CLAIX, France , Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ XtraFlow™ Glass Prefillable Syringe and the latest capacity expansion of the BD Neopak™ Glass Prefillable Syringe platform to serve the growing market for biologic therapies.

Prnewswire | 8 months ago
Here's Why Becton Dickinson (BDX) is a Strong Value Stock

Here's Why Becton Dickinson (BDX) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 9 months ago
Here's Why Becton Dickinson (BDX) is a Strong Growth Stock

Here's Why Becton Dickinson (BDX) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 9 months ago
BD Stock Falls After Acquisition of Edwards' Critical Care Group

BD Stock Falls After Acquisition of Edwards' Critical Care Group

BDX expands its smart care portfolio by acquiring Edwards Lifesciences' Critical Care group, now BD Advanced Patient Monitoring, strengthening AI-driven health solutions.

Zacks | 9 months ago
Becton, Dickinson and Company (BDX) Wells Fargo 2024 Healthcare Conference

Becton, Dickinson and Company (BDX) Wells Fargo 2024 Healthcare Conference

Becton, Dickinson and Company (NYSE:BDX ) Wells Fargo 2024 Healthcare Conference September 4, 2024 8:45 AM ET Company Participants Tom Polen - Chairman, President & CEO Conference Call Participants Lawrence Biegelsen - Wells Fargo Lawrence Biegelsen Welcome back. Good morning.

Seekingalpha | 9 months ago
BD Completes Acquisition of Critical Care from Edwards Lifesciences

BD Completes Acquisition of Critical Care from Edwards Lifesciences

Expands BD's portfolio of smart connected care solutions with leading monitoring technologies, including advanced AI-enabled clinical decision tools Combination of leading monitoring and infusion platforms enables future innovation opportunities for closed–loop monitoring and treatment, integrating combined company data sets and interoperability capabilities Business renamed as BD Advanced Patient Monitoring, will be based in Irvine, Calif. and become part of BD Medical segment Katie Szyman will continue to lead BD Advanced Patient Monitoring as worldwide president FRANKLIN LAKES, N.J.

Prnewswire | 9 months ago
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term

Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 9 months ago
BD Celebrates 75 years of U.S. Manufacturing Excellence in Nebraska

BD Celebrates 75 years of U.S. Manufacturing Excellence in Nebraska

Emphasizes Value of Domestic Production of Critical Medical Devices FRANKLIN LAKES, N.J. , Aug. 22, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today celebrated the 75th anniversary of its manufacturing operations in Columbus, Neb.

Prnewswire | 9 months ago
Loading...
Load More